Stock Updates

A look at a High Market Cap Stock: Thermo Fisher Scientific, Inc., TMO

Thermo Fisher Scientific, Inc., TMO is in the exchange NYSE and its industry is Medical Laboratories & Research in the sector of Healthcare. Based in USA, Thermo Fisher Scientific, Inc., TMO  has a market cap of 60003.56. Since its IPO date on the 9/1/1987, Thermo Fisher Scientific, Inc., TMO performance year to date is 2.64%. Today Thermo Fisher Scientific, Inc., TMO has gained -0.75%, with a current price of 145.15.

Ownership of the company is 0.20% for insider ownership while institutional ownership is 89.30%. The management of the company have seen the company have a payout ratio of *TBA. Return of assets are at *TBA, with return on investment at 7.00%.

In terms of debt levels and profit levels, Thermo Fisher Scientific, Inc., TMO is seeing a long-term debt/equity of 0.55. While Total debt/equity is 0.67. With a profit margin of *TBA, this is combined with a gross margin of 45.60%, and operating margin of *TBA. Thermo Fisher Scientific, Inc. ability to meet debt levels, with a current ratio of 1.1, while the quick ratio is 0.8.

For the last year Thermo Fisher Scientific, Inc., TMO has seen a EPS growth of 4.60%. A performance for the year of 19.32%. The 52-week high is -9.67%, and the 52-week low is 24.35%. The average volume for Thermo Fisher Scientific, Inc., TMO is 1924400.

With a target price of 172.06, can Thermo Fisher Scientific, Inc., TMO reach this target? Looking at the value indicators of Thermo Fisher Scientific, Inc., TMO. Thermo Fisher Scientific, Inc. has a P/E of 29 and a forward P/E of 16.1. Perhaps the more useful indicator than P/E, is PEG which has a value of 2.77. Thermo Fisher Scientific, Inc. also has a P/S and a P/B of 3.41 and 2.69 respectively. For P/cash, Thermo Fisher Scientific, Inc. has a value of *TBA, while it is *TBA for P/free cash flow.

At the current price of 145.15, Thermo Fisher Scientific, Inc. has a dividend yield of 0.41%. We see a return on equity of *TBA.

Looking more long-term Thermo Fisher Scientific, Inc., is projected to get an EPS growth for the next five years of 10.47%. In the short-term an EPS growth of 10.57% in the next year is forecasted. This is after a EPS growth of 4.60% for this year and for the last five years a 15.00% growth has been seen.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Stephen Butters

Leave a Comment